Although NRF2 is a cytoprotective factor and its transient activation is linked to chemoprevention, its sustained activation has been shown to protect cancer cells against chemo- and radiotherapy and promote metabolic activities that support cell proliferation and tumor growth [104]. The gene discussed is NFE2L2; the disease is cancer.